#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Orthostatic hypotension Chronic myelomonocytic leukaemia Oesophageal adenocarcinoma stage II Skin angiosarcoma Aspergillus infection Hyperphagia Juvenile chronic myelomonocytic leukaemia Congenital disorder of glycosylation Vascular calcification CDKL5 deficiency disorder Leiomyosarcoma recurrent Glomerulonephritis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Cardiac sarcoidosis Paraganglion neoplasm More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Diagnostics Mitochondrial myopathy – Treatment Castleman’s disease Malignant fibrous histiocytoma – Diagnostics Breast angiosarcoma – Trials in Disease Turner’s syndrome – Diagnostics Systemic mastocytosis – Trials in Disease Angiosarcoma non-metastatic – Diagnostics Richter’s syndrome – Treatment Gaucher’s disease type III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RIVASTIGMINE Xanthum Gum Autogene Cevumeran Nacubactam Imatinib CARBACHOL Colistin Sulfate Dasiglucagon Mifamurtide Art6043 IPN01195 Sodium Iodide (131I) Gentamicin Concizumab Lonapegsomatropin Ide397 Jab-21822 Sodium Hypochlorite Metamizole Magnesium Dorzolamide Hydrochloride More therapies…

    Learn about Your Condition

    Colon cancer metastatic Drug use disorder Skin neoplasm excision Skin wrinkling Ankylosing spondylitis Pericarditis Myocardial infarction Staphylococcal infection Immune-mediated renal disorder Lymphocytic lymphoma Thrombosis prophylaxis Bipolar I disorder Thyroidectomy Mucopolysaccharidosis III Congenital pseudarthrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Granulomatosis with polyangiitis

  • Study of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    • Systemic lupus erythematosus
    • Systemic scleroderma
    Investigated Drugs:
    • Blinatumomab
    Germany

  • Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Obinutuzumab
    France

  • Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone
    • Rituximab
    France

  • Study of Empagliflozin, Losartan Potassium and Hydrochlorothiazide to Prevent Kidney Stones in Patients with Paraffin Oil Induced Granulomatous Disease

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Losartan Potassium
    • Hydrochlorothiazide
    • Empagliflozin
    Denmark

  • Study on Rituximab, Tocilizumab, and Tofacitinib for Patients with Granulomatosis with Polyangiitis Not Responding to Standard Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Tofacitinib
    • Azathioprine
    • Methotrexate
    France

  • Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Microscopic polyangiitis
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Iptacopan
    Austria Belgium Czechia Denmark France Germany +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!